TGM2 and Cowden disease: In active CD patients, gene expression differed depending on whether anti‐TG2 levels were above (group Anti‐TG2‐based CD diagnosis) or below (group Biopsy‐based CD diagnosis) the recommended cut‐off (10 × ULN, [1]).